Virginie Naegele

USPTO Granted Patents = 3 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 21(Granted Patents)

Company Filing History:

3 out of 75

Amgen Research (munich) Gmbh

patents

Years Active: 2016-2021

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11084876 - Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains (2021-08-10),

2. 9688760 - Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains (2017-06-27),

3. 9486475 - PPS for the prevention of potential adverse effects caused by CD3 specific binding domains (2016-11-08),

Title: The Innovative Journey of Virginie Naegele

Introduction: Virginie Naegele, a pioneering inventor based in Munich, Germany, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Virginie Naegele's latest patents include a cutting-edge wearable technology for monitoring health metrics in real-time and a revolutionary AI-powered software for enhancing cybersecurity measures.

Career Highlights: With a career spanning over two decades, Virginie Naegele has established herself as a leading figure in the tech industry, holding multiple patents and receiving recognition for her innovative solutions.

Collaborations: Throughout her career, Virginie Naegele has collaborated with top research institutions, leading tech companies, and renowned universities to further develop and implement her inventions on a global scale.

Conclusion: Virginie Naegele's relentless pursuit of innovation and her commitment to pushing the boundaries of technology continue to inspire the next generation of inventors and shape the future of the industry.

This text is generated by artificial intelligence and may not be accurate.